Global Personalized Medicine (PM) Solution Market Size, Industry Analysis By Segmentations, Top Key Players, Trends, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 3/1/2023
- NO OF PAGES
- 262
- CATEGORY
- Information Technology
Personalized Medicine (PM) Solution market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain which gives brief strategy of market growth during the forecast period. It also gives in-depth insights on SWOT and PESTLE analysis based on industry segmentations and regional developments.
Market Overview:
The report provides a basic overview of the industry including definitions, classifications, and industry chain structure. The Personalized Medicine (PM) Solution market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand, price, revenue and gross margins.
Report Scope:
The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Personalized Medicine (PM) Solution manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases. The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment by type, application and region and as a result provides a holistic view of as well as a deep insight into the Personalized Medicine (PM) Solution market covering all its essential aspects.
Global Personalized Medicine (PM) Solution Market: Segmentations
Global Personalized Medicine (PM) Solution Market: By Types
Personalized Diagnostics
Personalized Therapies
Personalized Nutrition & Wellness
Global Personalized Medicine (PM) Solution Market: By Applications
Oncology
Neurosciences
Immunology
Respiratory
Others
Global Personalized Medicine (PM) Solution Market: Major Players
2bPrecise
OneOme
TIGAR Health- IR2Dx
Kailos Genetics
Syapse Inc
Karius
Astarte Medical
Fabric Genomics, INC.
Orion Health
2B Precise
Fabric Genomics
Pfizer
Gene 42
IBM Watson Health
Philips Healthcare
Medtronic
Nanthealth
Navican
N-of-One
PierianDx
Sunquest Information System
Tempus
Novartis
Translational Software
Biocrates Life Sciences AG
Nanostring Technologies
Thermo Fisher Scientific
Quest Diagnostics Incorporated
Global Personalized Medicine (PM) Solution Market: By Regions
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Personalized Medicine (PM) Solution market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Personalized Medicine (PM) Solution would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Personalized Medicine (PM) Solution Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Base Year: 2023Market Overview:
The report provides a basic overview of the industry including definitions, classifications, and industry chain structure. The Personalized Medicine (PM) Solution market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand, price, revenue and gross margins.
Report Scope:
The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Personalized Medicine (PM) Solution manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases. The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment by type, application and region and as a result provides a holistic view of as well as a deep insight into the Personalized Medicine (PM) Solution market covering all its essential aspects.
Global Personalized Medicine (PM) Solution Market: Segmentations
Global Personalized Medicine (PM) Solution Market: By Types
Personalized Diagnostics
Personalized Therapies
Personalized Nutrition & Wellness
Global Personalized Medicine (PM) Solution Market: By Applications
Oncology
Neurosciences
Immunology
Respiratory
Others
Global Personalized Medicine (PM) Solution Market: Major Players
2bPrecise
OneOme
TIGAR Health- IR2Dx
Kailos Genetics
Syapse Inc
Karius
Astarte Medical
Fabric Genomics, INC.
Orion Health
2B Precise
Fabric Genomics
Pfizer
Gene 42
IBM Watson Health
Philips Healthcare
Medtronic
Nanthealth
Navican
N-of-One
PierianDx
Sunquest Information System
Tempus
Novartis
Translational Software
Biocrates Life Sciences AG
Nanostring Technologies
Thermo Fisher Scientific
Quest Diagnostics Incorporated
Global Personalized Medicine (PM) Solution Market: By Regions
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Personalized Medicine (PM) Solution market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Personalized Medicine (PM) Solution would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Personalized Medicine (PM) Solution Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Historic Year: 2016-2022
Forecast: 2024-2035
1 Market Overview
1.1 Product Overview and Scope of Personalized Medicine (PM) Solution
1.2 Classification of Personalized Medicine (PM) Solution by Type
1.2.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Type: 2017 Versus 2022 Versus 2032
1.2.2 Global Personalized Medicine (PM) Solution Revenue Market Share by Type in 2022
1.2.3 Personalized Diagnostics
1.2.4 Personalized Therapies
1.2.5 Personalized Nutrition & Wellness
1.3 Global Personalized Medicine (PM) Solution Market by Application
1.3.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Application: 2017 Versus 2022 Versus 2032
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Global Personalized Medicine (PM) Solution Market Size & Forecast
1.5 Global Personalized Medicine (PM) Solution Market Size and Forecast by Region
1.5.1 Global Personalized Medicine (PM) Solution Market Size by Region: 2017 VS 2022 VS 2032
1.5.2 Global Personalized Medicine (PM) Solution Market Size by Region, (2016-2021)
1.5.3 North America Personalized Medicine (PM) Solution Market Size and Prospect (2017-2032)
1.5.4 Europe Personalized Medicine (PM) Solution Market Size and Prospect (2017-2032)
1.5.5 Asia-Pacific Personalized Medicine (PM) Solution Market Size and Prospect (2017-2032)
1.5.6 South America Personalized Medicine (PM) Solution Market Size and Prospect (2017-2032)
1.5.7 Middle East and Africa Personalized Medicine (PM) Solution Market Size and Prospect (2017-2032)
1.6 Market Drivers, Restraints and Trends
1.6.1 Personalized Medicine (PM) Solution Market Drivers
1.6.2 Personalized Medicine (PM) Solution Market Restraints
1.6.3 Personalized Medicine (PM) Solution Trends Analysis
2 Company Profiles
2.1 2bPrecise
2.1.1 2bPrecise Details
2.1.2 2bPrecise Major Business
2.1.3 2bPrecise Personalized Medicine (PM) Solution Product and Solutions
2.1.4 2bPrecise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 2bPrecise Recent Developments and Future Plans
2.2 OneOme
2.2.1 OneOme Details
2.2.2 OneOme Major Business
2.2.3 OneOme Personalized Medicine (PM) Solution Product and Solutions
2.2.4 OneOme Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 OneOme Recent Developments and Future Plans
2.3 TIGAR Health- IR2Dx
2.3.1 TIGAR Health- IR2Dx Details
2.3.2 TIGAR Health- IR2Dx Major Business
2.3.3 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Product and Solutions
2.3.4 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 TIGAR Health- IR2Dx Recent Developments and Future Plans
2.4 Kailos Genetics
2.4.1 Kailos Genetics Details
2.4.2 Kailos Genetics Major Business
2.4.3 Kailos Genetics Personalized Medicine (PM) Solution Product and Solutions
2.4.4 Kailos Genetics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Kailos Genetics Recent Developments and Future Plans
2.5 Syapse Inc
2.5.1 Syapse Inc Details
2.5.2 Syapse Inc Major Business
2.5.3 Syapse Inc Personalized Medicine (PM) Solution Product and Solutions
2.5.4 Syapse Inc Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Syapse Inc Recent Developments and Future Plans
2.6 Karius
2.6.1 Karius Details
2.6.2 Karius Major Business
2.6.3 Karius Personalized Medicine (PM) Solution Product and Solutions
2.6.4 Karius Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Karius Recent Developments and Future Plans
2.7 Astarte Medical
2.7.1 Astarte Medical Details
2.7.2 Astarte Medical Major Business
2.7.3 Astarte Medical Personalized Medicine (PM) Solution Product and Solutions
2.7.4 Astarte Medical Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Astarte Medical Recent Developments and Future Plans
2.8 Fabric Genomics, INC.
2.8.1 Fabric Genomics, INC. Details
2.8.2 Fabric Genomics, INC. Major Business
2.8.3 Fabric Genomics, INC. Personalized Medicine (PM) Solution Product and Solutions
2.8.4 Fabric Genomics, INC. Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Fabric Genomics, INC. Recent Developments and Future Plans
2.9 Orion Health
2.9.1 Orion Health Details
2.9.2 Orion Health Major Business
2.9.3 Orion Health Personalized Medicine (PM) Solution Product and Solutions
2.9.4 Orion Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Orion Health Recent Developments and Future Plans
2.10 2B Precise
2.10.1 2B Precise Details
2.10.2 2B Precise Major Business
2.10.3 2B Precise Personalized Medicine (PM) Solution Product and Solutions
2.10.4 2B Precise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 2B Precise Recent Developments and Future Plans
2.11 Fabric Genomics
2.11.1 Fabric Genomics Details
2.11.2 Fabric Genomics Major Business
2.11.3 Fabric Genomics Personalized Medicine (PM) Solution Product and Solutions
2.11.4 Fabric Genomics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Fabric Genomics Recent Developments and Future Plans
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Personalized Medicine (PM) Solution Product and Solutions
2.12.4 Pfizer Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 Pfizer Recent Developments and Future Plans
2.13 Gene 42
2.13.1 Gene 42 Details
2.13.2 Gene 42 Major Business
2.13.3 Gene 42 Personalized Medicine (PM) Solution Product and Solutions
2.13.4 Gene 42 Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 Gene 42 Recent Developments and Future Plans
2.14 IBM Watson Health
2.14.1 IBM Watson Health Details
2.14.2 IBM Watson Health Major Business
2.14.3 IBM Watson Health Personalized Medicine (PM) Solution Product and Solutions
2.14.4 IBM Watson Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 IBM Watson Health Recent Developments and Future Plans
2.15 Philips Healthcare
2.15.1 Philips Healthcare Details
2.15.2 Philips Healthcare Major Business
2.15.3 Philips Healthcare Personalized Medicine (PM) Solution Product and Solutions
2.15.4 Philips Healthcare Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.15.5 Philips Healthcare Recent Developments and Future Plans
2.16 Medtronic
2.16.1 Medtronic Details
2.16.2 Medtronic Major Business
2.16.3 Medtronic Personalized Medicine (PM) Solution Product and Solutions
2.16.4 Medtronic Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.16.5 Medtronic Recent Developments and Future Plans
2.17 Nanthealth
2.17.1 Nanthealth Details
2.17.2 Nanthealth Major Business
2.17.3 Nanthealth Personalized Medicine (PM) Solution Product and Solutions
2.17.4 Nanthealth Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.17.5 Nanthealth Recent Developments and Future Plans
2.18 Navican
2.18.1 Navican Details
2.18.2 Navican Major Business
2.18.3 Navican Personalized Medicine (PM) Solution Product and Solutions
2.18.4 Navican Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.18.5 Navican Recent Developments and Future Plans
2.19 N-of-One
2.19.1 N-of-One Details
2.19.2 N-of-One Major Business
2.19.3 N-of-One Personalized Medicine (PM) Solution Product and Solutions
2.19.4 N-of-One Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.19.5 N-of-One Recent Developments and Future Plans
2.20 PierianDx
2.20.1 PierianDx Details
2.20.2 PierianDx Major Business
2.20.3 PierianDx Personalized Medicine (PM) Solution Product and Solutions
2.20.4 PierianDx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.20.5 PierianDx Recent Developments and Future Plans
2.21 Sunquest Information System
2.21.1 Sunquest Information System Details
2.21.2 Sunquest Information System Major Business
2.21.3 Sunquest Information System Personalized Medicine (PM) Solution Product and Solutions
2.21.4 Sunquest Information System Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.21.5 Sunquest Information System Recent Developments and Future Plans
2.22 Tempus
2.22.1 Tempus Details
2.22.2 Tempus Major Business
2.22.3 Tempus Personalized Medicine (PM) Solution Product and Solutions
2.22.4 Tempus Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.22.5 Tempus Recent Developments and Future Plans
2.23 Novartis
2.23.1 Novartis Details
2.23.2 Novartis Major Business
2.23.3 Novartis Personalized Medicine (PM) Solution Product and Solutions
2.23.4 Novartis Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.23.5 Novartis Recent Developments and Future Plans
2.24 Translational Software
2.24.1 Translational Software Details
2.24.2 Translational Software Major Business
2.24.3 Translational Software Personalized Medicine (PM) Solution Product and Solutions
2.24.4 Translational Software Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.24.5 Translational Software Recent Developments and Future Plans
2.25 Biocrates Life Sciences AG
2.25.1 Biocrates Life Sciences AG Details
2.25.2 Biocrates Life Sciences AG Major Business
2.25.3 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Product and Solutions
2.25.4 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.25.5 Biocrates Life Sciences AG Recent Developments and Future Plans
2.26 Nanostring Technologies
2.26.1 Nanostring Technologies Details
2.26.2 Nanostring Technologies Major Business
2.26.3 Nanostring Technologies Personalized Medicine (PM) Solution Product and Solutions
2.26.4 Nanostring Technologies Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.26.5 Nanostring Technologies Recent Developments and Future Plans
2.27 Thermo Fisher Scientific
2.27.1 Thermo Fisher Scientific Details
2.27.2 Thermo Fisher Scientific Major Business
2.27.3 Thermo Fisher Scientific Personalized Medicine (PM) Solution Product and Solutions
2.27.4 Thermo Fisher Scientific Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.27.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.28 Quest Diagnostics Incorporated
2.28.1 Quest Diagnostics Incorporated Details
2.28.2 Quest Diagnostics Incorporated Major Business
2.28.3 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Product and Solutions
2.28.4 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.28.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Personalized Medicine (PM) Solution Revenue and Share by Players (2017-2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Personalized Medicine (PM) Solution Players Market Share
3.2.2 Top 10 Personalized Medicine (PM) Solution Players Market Share
3.2.3 Market Competition Trend
3.3 Personalized Medicine (PM) Solution Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Personalized Medicine (PM) Solution Revenue and Market Share by Type (2016-2021)
4.2 Global Personalized Medicine (PM) Solution Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Personalized Medicine (PM) Solution Revenue Market Share by Application (2016-2021)
5.2 Personalized Medicine (PM) Solution Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Personalized Medicine (PM) Solution Revenue by Type (2017-2032)
6.2 North America Personalized Medicine (PM) Solution Revenue by Application (2017-2032)
6.3 North America Personalized Medicine (PM) Solution Market Size by Country
6.3.1 North America Personalized Medicine (PM) Solution Revenue by Country (2017-2032)
6.3.2 United States Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
6.3.3 Canada Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
6.3.4 Mexico Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
7 Europe by Country, by Type, and by Application
7.1 Europe Personalized Medicine (PM) Solution Revenue by Type (2017-2032)
7.2 Europe Personalized Medicine (PM) Solution Revenue by Application (2017-2032)
7.3 Europe Personalized Medicine (PM) Solution Market Size by Country
7.3.1 Europe Personalized Medicine (PM) Solution Revenue by Country (2017-2032)
7.3.2 Germany Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
7.3.3 France Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
7.3.4 United Kingdom Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
7.3.5 Russia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
7.3.6 Italy Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Type (2017-2032)
8.2 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Application (2017-2032)
8.3 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region
8.3.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Region (2017-2032)
8.3.2 China Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
8.3.3 Japan Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
8.3.4 South Korea Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
8.3.5 India Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
8.3.6 Southeast Asia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
8.3.7 Australia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
9 South America by Country, by Type, and by Application
9.1 South America Personalized Medicine (PM) Solution Revenue by Type (2017-2032)
9.2 South America Personalized Medicine (PM) Solution Revenue by Application (2017-2032)
9.3 South America Personalized Medicine (PM) Solution Market Size by Country
9.3.1 South America Personalized Medicine (PM) Solution Revenue by Country (2017-2032)
9.3.2 Brazil Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
9.3.3 Argentina Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Type (2017-2032)
10.2 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Application (2017-2032)
10.3 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country
10.3.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Country (2017-2032)
10.3.2 Turkey Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
10.3.3 Saudi Arabia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
10.3.4 UAE Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Personalized Medicine (PM) Solution
1.2 Classification of Personalized Medicine (PM) Solution by Type
1.2.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Type: 2017 Versus 2022 Versus 2032
1.2.2 Global Personalized Medicine (PM) Solution Revenue Market Share by Type in 2022
1.2.3 Personalized Diagnostics
1.2.4 Personalized Therapies
1.2.5 Personalized Nutrition & Wellness
1.3 Global Personalized Medicine (PM) Solution Market by Application
1.3.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Application: 2017 Versus 2022 Versus 2032
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Global Personalized Medicine (PM) Solution Market Size & Forecast
1.5 Global Personalized Medicine (PM) Solution Market Size and Forecast by Region
1.5.1 Global Personalized Medicine (PM) Solution Market Size by Region: 2017 VS 2022 VS 2032
1.5.2 Global Personalized Medicine (PM) Solution Market Size by Region, (2016-2021)
1.5.3 North America Personalized Medicine (PM) Solution Market Size and Prospect (2017-2032)
1.5.4 Europe Personalized Medicine (PM) Solution Market Size and Prospect (2017-2032)
1.5.5 Asia-Pacific Personalized Medicine (PM) Solution Market Size and Prospect (2017-2032)
1.5.6 South America Personalized Medicine (PM) Solution Market Size and Prospect (2017-2032)
1.5.7 Middle East and Africa Personalized Medicine (PM) Solution Market Size and Prospect (2017-2032)
1.6 Market Drivers, Restraints and Trends
1.6.1 Personalized Medicine (PM) Solution Market Drivers
1.6.2 Personalized Medicine (PM) Solution Market Restraints
1.6.3 Personalized Medicine (PM) Solution Trends Analysis
2 Company Profiles
2.1 2bPrecise
2.1.1 2bPrecise Details
2.1.2 2bPrecise Major Business
2.1.3 2bPrecise Personalized Medicine (PM) Solution Product and Solutions
2.1.4 2bPrecise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 2bPrecise Recent Developments and Future Plans
2.2 OneOme
2.2.1 OneOme Details
2.2.2 OneOme Major Business
2.2.3 OneOme Personalized Medicine (PM) Solution Product and Solutions
2.2.4 OneOme Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 OneOme Recent Developments and Future Plans
2.3 TIGAR Health- IR2Dx
2.3.1 TIGAR Health- IR2Dx Details
2.3.2 TIGAR Health- IR2Dx Major Business
2.3.3 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Product and Solutions
2.3.4 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 TIGAR Health- IR2Dx Recent Developments and Future Plans
2.4 Kailos Genetics
2.4.1 Kailos Genetics Details
2.4.2 Kailos Genetics Major Business
2.4.3 Kailos Genetics Personalized Medicine (PM) Solution Product and Solutions
2.4.4 Kailos Genetics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Kailos Genetics Recent Developments and Future Plans
2.5 Syapse Inc
2.5.1 Syapse Inc Details
2.5.2 Syapse Inc Major Business
2.5.3 Syapse Inc Personalized Medicine (PM) Solution Product and Solutions
2.5.4 Syapse Inc Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Syapse Inc Recent Developments and Future Plans
2.6 Karius
2.6.1 Karius Details
2.6.2 Karius Major Business
2.6.3 Karius Personalized Medicine (PM) Solution Product and Solutions
2.6.4 Karius Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Karius Recent Developments and Future Plans
2.7 Astarte Medical
2.7.1 Astarte Medical Details
2.7.2 Astarte Medical Major Business
2.7.3 Astarte Medical Personalized Medicine (PM) Solution Product and Solutions
2.7.4 Astarte Medical Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Astarte Medical Recent Developments and Future Plans
2.8 Fabric Genomics, INC.
2.8.1 Fabric Genomics, INC. Details
2.8.2 Fabric Genomics, INC. Major Business
2.8.3 Fabric Genomics, INC. Personalized Medicine (PM) Solution Product and Solutions
2.8.4 Fabric Genomics, INC. Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Fabric Genomics, INC. Recent Developments and Future Plans
2.9 Orion Health
2.9.1 Orion Health Details
2.9.2 Orion Health Major Business
2.9.3 Orion Health Personalized Medicine (PM) Solution Product and Solutions
2.9.4 Orion Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Orion Health Recent Developments and Future Plans
2.10 2B Precise
2.10.1 2B Precise Details
2.10.2 2B Precise Major Business
2.10.3 2B Precise Personalized Medicine (PM) Solution Product and Solutions
2.10.4 2B Precise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 2B Precise Recent Developments and Future Plans
2.11 Fabric Genomics
2.11.1 Fabric Genomics Details
2.11.2 Fabric Genomics Major Business
2.11.3 Fabric Genomics Personalized Medicine (PM) Solution Product and Solutions
2.11.4 Fabric Genomics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Fabric Genomics Recent Developments and Future Plans
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Personalized Medicine (PM) Solution Product and Solutions
2.12.4 Pfizer Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 Pfizer Recent Developments and Future Plans
2.13 Gene 42
2.13.1 Gene 42 Details
2.13.2 Gene 42 Major Business
2.13.3 Gene 42 Personalized Medicine (PM) Solution Product and Solutions
2.13.4 Gene 42 Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 Gene 42 Recent Developments and Future Plans
2.14 IBM Watson Health
2.14.1 IBM Watson Health Details
2.14.2 IBM Watson Health Major Business
2.14.3 IBM Watson Health Personalized Medicine (PM) Solution Product and Solutions
2.14.4 IBM Watson Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 IBM Watson Health Recent Developments and Future Plans
2.15 Philips Healthcare
2.15.1 Philips Healthcare Details
2.15.2 Philips Healthcare Major Business
2.15.3 Philips Healthcare Personalized Medicine (PM) Solution Product and Solutions
2.15.4 Philips Healthcare Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.15.5 Philips Healthcare Recent Developments and Future Plans
2.16 Medtronic
2.16.1 Medtronic Details
2.16.2 Medtronic Major Business
2.16.3 Medtronic Personalized Medicine (PM) Solution Product and Solutions
2.16.4 Medtronic Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.16.5 Medtronic Recent Developments and Future Plans
2.17 Nanthealth
2.17.1 Nanthealth Details
2.17.2 Nanthealth Major Business
2.17.3 Nanthealth Personalized Medicine (PM) Solution Product and Solutions
2.17.4 Nanthealth Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.17.5 Nanthealth Recent Developments and Future Plans
2.18 Navican
2.18.1 Navican Details
2.18.2 Navican Major Business
2.18.3 Navican Personalized Medicine (PM) Solution Product and Solutions
2.18.4 Navican Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.18.5 Navican Recent Developments and Future Plans
2.19 N-of-One
2.19.1 N-of-One Details
2.19.2 N-of-One Major Business
2.19.3 N-of-One Personalized Medicine (PM) Solution Product and Solutions
2.19.4 N-of-One Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.19.5 N-of-One Recent Developments and Future Plans
2.20 PierianDx
2.20.1 PierianDx Details
2.20.2 PierianDx Major Business
2.20.3 PierianDx Personalized Medicine (PM) Solution Product and Solutions
2.20.4 PierianDx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.20.5 PierianDx Recent Developments and Future Plans
2.21 Sunquest Information System
2.21.1 Sunquest Information System Details
2.21.2 Sunquest Information System Major Business
2.21.3 Sunquest Information System Personalized Medicine (PM) Solution Product and Solutions
2.21.4 Sunquest Information System Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.21.5 Sunquest Information System Recent Developments and Future Plans
2.22 Tempus
2.22.1 Tempus Details
2.22.2 Tempus Major Business
2.22.3 Tempus Personalized Medicine (PM) Solution Product and Solutions
2.22.4 Tempus Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.22.5 Tempus Recent Developments and Future Plans
2.23 Novartis
2.23.1 Novartis Details
2.23.2 Novartis Major Business
2.23.3 Novartis Personalized Medicine (PM) Solution Product and Solutions
2.23.4 Novartis Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.23.5 Novartis Recent Developments and Future Plans
2.24 Translational Software
2.24.1 Translational Software Details
2.24.2 Translational Software Major Business
2.24.3 Translational Software Personalized Medicine (PM) Solution Product and Solutions
2.24.4 Translational Software Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.24.5 Translational Software Recent Developments and Future Plans
2.25 Biocrates Life Sciences AG
2.25.1 Biocrates Life Sciences AG Details
2.25.2 Biocrates Life Sciences AG Major Business
2.25.3 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Product and Solutions
2.25.4 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.25.5 Biocrates Life Sciences AG Recent Developments and Future Plans
2.26 Nanostring Technologies
2.26.1 Nanostring Technologies Details
2.26.2 Nanostring Technologies Major Business
2.26.3 Nanostring Technologies Personalized Medicine (PM) Solution Product and Solutions
2.26.4 Nanostring Technologies Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.26.5 Nanostring Technologies Recent Developments and Future Plans
2.27 Thermo Fisher Scientific
2.27.1 Thermo Fisher Scientific Details
2.27.2 Thermo Fisher Scientific Major Business
2.27.3 Thermo Fisher Scientific Personalized Medicine (PM) Solution Product and Solutions
2.27.4 Thermo Fisher Scientific Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.27.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.28 Quest Diagnostics Incorporated
2.28.1 Quest Diagnostics Incorporated Details
2.28.2 Quest Diagnostics Incorporated Major Business
2.28.3 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Product and Solutions
2.28.4 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2017-2022)
2.28.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Personalized Medicine (PM) Solution Revenue and Share by Players (2017-2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Personalized Medicine (PM) Solution Players Market Share
3.2.2 Top 10 Personalized Medicine (PM) Solution Players Market Share
3.2.3 Market Competition Trend
3.3 Personalized Medicine (PM) Solution Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Personalized Medicine (PM) Solution Revenue and Market Share by Type (2016-2021)
4.2 Global Personalized Medicine (PM) Solution Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Personalized Medicine (PM) Solution Revenue Market Share by Application (2016-2021)
5.2 Personalized Medicine (PM) Solution Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Personalized Medicine (PM) Solution Revenue by Type (2017-2032)
6.2 North America Personalized Medicine (PM) Solution Revenue by Application (2017-2032)
6.3 North America Personalized Medicine (PM) Solution Market Size by Country
6.3.1 North America Personalized Medicine (PM) Solution Revenue by Country (2017-2032)
6.3.2 United States Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
6.3.3 Canada Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
6.3.4 Mexico Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
7 Europe by Country, by Type, and by Application
7.1 Europe Personalized Medicine (PM) Solution Revenue by Type (2017-2032)
7.2 Europe Personalized Medicine (PM) Solution Revenue by Application (2017-2032)
7.3 Europe Personalized Medicine (PM) Solution Market Size by Country
7.3.1 Europe Personalized Medicine (PM) Solution Revenue by Country (2017-2032)
7.3.2 Germany Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
7.3.3 France Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
7.3.4 United Kingdom Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
7.3.5 Russia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
7.3.6 Italy Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Type (2017-2032)
8.2 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Application (2017-2032)
8.3 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region
8.3.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Region (2017-2032)
8.3.2 China Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
8.3.3 Japan Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
8.3.4 South Korea Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
8.3.5 India Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
8.3.6 Southeast Asia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
8.3.7 Australia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
9 South America by Country, by Type, and by Application
9.1 South America Personalized Medicine (PM) Solution Revenue by Type (2017-2032)
9.2 South America Personalized Medicine (PM) Solution Revenue by Application (2017-2032)
9.3 South America Personalized Medicine (PM) Solution Market Size by Country
9.3.1 South America Personalized Medicine (PM) Solution Revenue by Country (2017-2032)
9.3.2 Brazil Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
9.3.3 Argentina Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Type (2017-2032)
10.2 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Application (2017-2032)
10.3 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country
10.3.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Country (2017-2032)
10.3.2 Turkey Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
10.3.3 Saudi Arabia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
10.3.4 UAE Personalized Medicine (PM) Solution Market Size and Forecast (2017-2032)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Pricing
Select a license type that suits your business needs
Single User Access
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
Multi User Cost
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
Enterprise User Cost
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI